Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells

The Role of Estrogen and Estrogen Receptors in Chemoresistance

(2012) M. Sui et al.   CURRENT MEDICINAL CHEMISTRY

One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor

(2011) Levin Böhlig et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

p53 Binds to Estrogen Receptor 1 Promoter in Human Breast Cancer Cells

(2011) Mozhgan Rasti et al.   PATHOLOGY & ONCOLOGY RESEARCH

Regulation of DNA methyltransferase 1 by interactions and modifications

(2011) Weihua Qin et al.   Nucleus

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

Mutant p53 mediates survival of breast cancer cells

(2009) L Y Lim et al.   BRITISH JOURNAL OF CANCER

Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression

(2009) M. O. Hoque et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Transcriptional Regulation of Estrogen Receptor-  by p53 in Human Breast Cancer Cells

(2009) S. H. Shirley et al.   CANCER RESEARCH

KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα

(2009) K Akaogi et al.   ONCOGENE

Silencing of estrogen receptor α (ERα) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer

(2008) Lin Zhao et al.   BREAST CANCER RESEARCH AND TREATMENT

Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2

(2008) G. Dhar et al.   CANCER RESEARCH

Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53

(2008) Ji-Ching Lai et al.   DNA REPAIR

Epigenomics and breast cancer

(2008) Pang-Kuo Lo et al.   PHARMACOGENOMICS